Skip to content
10-K

Annual Report

NANOVIRICIDES, INC. NNVC

0001410578-24-001650

← back to feed
Filed
Sep 27, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Sep 27, 2024 14.68M sh
Total Liabilities FY 2024 · Jun 30, 2024 $1.36M
Total Liabilities FY 2024 · Jun 30, 2023 $2.03M
Shares Diluted FY 2024 · Jun 30, 2023 11.63M sh
Capex FY 2024 · Jun 30, 2023 $151.71K
Operating Cash Flow FY 2024 · Jun 30, 2023 −$5.67M
Cash And Equivalents FY 2024 · Jun 30, 2023 $8.15M
Current Liabilities FY 2024 · Jun 30, 2023 $534.25K
Current Assets FY 2024 · Jun 30, 2023 $8.45M
Total Assets FY 2024 · Jun 30, 2023 $16.9M
Eps Diluted FY 2024 · Jun 30, 2023 −$0.74
Eps Basic FY 2024 · Jun 30, 2023 −$0.74
Sga Expense FY 2024 · Jun 30, 2023 $2.55M
Rd Expense FY 2024 · Jun 30, 2023 $6.39M
Net Income FY 2024 · Jun 30, 2023 −$8.59M
Operating Income FY 2024 · Jun 30, 2023 −$8.94M
Stockholders Equity FY 2024 · Jun 30, 2022 $23.08M